Meloxicam Viatris

Meloxicam, the active ingredient in Meloxicam Viatris, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It treats pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute musculoskeletal pain in adult patients.

GNH USA supplies Meloxicam Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is used to manage inflammatory and painful conditions affecting the musculoskeletal system.

- Osteoarthritis: reduces joint pain and improves functional mobility. - Rheumatoid arthritis: alleviates inflammation and joint swelling, helping maintain range of motion. - Ankylosing spondylitis: diminishes spinal pain and stiffness, supporting better posture and activity. - Acute pain: provides rapid relief of moderate to severe pain from injuries or postoperative settings.

Meloxicam may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Gastrointestinal upset (nausea, dyspepsia) - Headache - Dizziness - Peripheral edema - Elevated blood pressure

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation - Cardiovascular events such as myocardial infarction or stroke - Severe liver enzyme elevation or hepatitis - Acute kidney injury - Life‑threatening skin reactions (e.g., Stevens‑Johnson syndrome)

When prescribing meloxicam, clinicians should consider several safety measures to minimize risk.

- Assess renal function: evaluate baseline creatinine and adjust use in impairment. - Monitor blood pressure: watch for hypertension, especially in long‑term therapy. - Use lowest effective dose: limit duration to the shortest period needed for symptom control. - Avoid in patients with known hypersensitivity to NSAIDs or sulfonamides. - Caution with concomitant anticoagulants: increased bleeding risk. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Meloxicam can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened risk of serious bleeding. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Lithium: meloxicam may increase lithium serum levels, risking toxicity. - Methotrexate: reduced clearance may lead to toxicity.

Moderate Interactions (Monitor Closely): - Diuretics and antihypertensives: possible reduction in renal function and blood pressure control. - Selective serotonin reuptake inhibitors (SSRIs): modest increase in bleeding risk. - Corticosteroids: enhanced gastrointestinal adverse effects.